Elevance Health (ELV) Current Deferred Revenue (2009 - 2026)

Elevance Health (ELV) has 18 years of Current Deferred Revenue data on file, last reported at $1.8 billion in Q1 2026.

• Current Deferred Revenue for Q1 2026 came in at $1.8 billion, up 7.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 7.26% YoY), and the FY2025 annual result was $1.5 billion, down 0.99% from the prior year.
• Current Deferred Revenue grew to $1.8 billion in Q1 2026 per ELV's latest filing, from $1.5 billion in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $4.5 billion in Q2 2023 and troughed at $971.0 million in Q2 2022.
• A 5-year average of $2.1 billion and a median of $1.6 billion in 2025 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue soared 359.11% in 2023, then plunged 66.78% in 2024.
• A 5-year view of Current Deferred Revenue shows it stood at $1.1 billion in 2022, then advanced by 26.08% to $1.4 billion in 2023, then rose by 7.56% to $1.5 billion in 2024, then decreased by 0.99% to $1.5 billion in 2025, then advanced by 17.82% to $1.8 billion in 2026.
• Business Quant data shows ELV's Current Deferred Revenue at $1.8 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.8 billion in Q3 2025.